Eagle Global Advisors LLC Bristol Myers Squibb CO Transaction History

Eagle Global Advisors LLC

  • $1.96 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 01, 2018
SELL
$50.53 - $62.98 $164,222 - $204,685
-3,250 Closed
0 $0
Q1 2018

May 04, 2018
SELL
$59.92 - $68.98 $72,802 - $83,810
-1,215 Reduced 27.21%
3,250 $206,000
Q3 2017

Nov 13, 2017
BUY
$55.23 - $63.74 $246,601 - $284,599
4,465
4,465 $285,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Eagle Global Advisors LLC Portfolio

Follow Eagle Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Global Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email